I-care Enters into Licensing Agreement with Massachusetts Institute of Technology (MIT)
Boston, June 10, 2022 – I-care Group, a global leader in machine health, has signed a non-exclusive license agreement with U.S.-based Massachusetts Institute of Technology (MIT) for a group of MIT patents covering breakthrough machinery monitoring technology.
The patents include algorithms that transform standard high speed photography into an advanced sensor array for machinery analysis. Previously, performing a structural analysis on a plant asset required days to complete. With this technology, superior analysis can be completed in minutes and in greater detail without even touching the machine.
Ben Detober, CEO of I-care USA and representative of I-care Group: “We are very proud and honored to sign this agreement with the renowned MIT and to benefit from their incredible technology. I-care helps industries around the world to be safer, more productive and more sustainable. We invest heavily in our R&D in order to keep improving our technology, products and services. Thanks to the MIT agreement, I-care will offer our clients even better technology: our teams will more quickly and easily identify the nature of defects on plant equipment and recommend appropriate corrective actions.”
I-care monitors industrial equipment 24/7 in thousands of plants across the food, chemical, pharmaceutical, energy and materials sectors.
About I-care Group
I-care Group is a world leader in machine health. Their AI- and data-driven solutions can predict industrial failures months or even years before they occur. Thanks to I-care, machines around the world are safer, more productive and more sustainable. Founded in Mons in 2004, the company has more than 600 employees and offices in 12 countries (Americas, Europe and Asia-Pacific) with customers in more than 55 countries. I-care won the EY Company of the Year Award in 2020.
Juliette Picry, email@example.com